HCA vs CHE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 12, 2026

HCA

61.8
AI Score
VS
HCA Wins

CHE

57.8
AI Score

Investment Advisor Scores

HCA

62score
Recommendation
BUY

CHE

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric HCA CHE Winner
Revenue 19.11B 1.79B HCA
Net Income 1.62B 211.68M HCA
Net Margin 8.5% 11.8% CHE
ROE -25.7% 17.1% CHE
ROA 2.6% 12.0% CHE
Total Assets 61.45B 1.77B HCA
Cash 940.00M 238.45M HCA
Current Ratio 0.83 1.85 CHE
Free Cash Flow 895.00M 215.81M HCA

Relative Price Performance (Last 90 Days)

HCA 1M: +2.4% · 3M: -7.3% CHE 1M: +10.7% · 3M: +25.2%

Current Technical Phase

HCA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.4 · Price: $402.59

CHE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.6% over 20 days), RSI 73

RSI (14): 73.1 · Price: $532.25

Fundamentals Snapshot

Metric HCA CHE
Market Cap
Forward P/E 12.5 19.8
Trailing P/E 13.7 26.9
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.4% 0.3%
Operating Margin 0.2% 0.1%
EPS 28.93 19.90
Dividend Yield 0.01% 0.00%

Frequently Asked Questions

Based on our detailed analysis, HCA is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.